BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 24853648)

  • 1. Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.
    Zhou SY; Xie ZL; Xiao O; Yang XR; Heng BC; Sato Y
    Mol Vis; 2010 Jul; 16():1389-98. PubMed ID: 20680097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1α.
    Fu YC; Xin ZM
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
    Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
    J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.
    Sun MM; Chan AM; Law SM; Duarte S; Diaz-Aguilar D; Wadehra M; Gordon LK
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):245-254. PubMed ID: 30646013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
    Qiu F; Shin Y; Chen D; Cheng R; Chen Q; Zhou K; Larrick JW; Mendelson AR; Ma JX
    Microvasc Res; 2018 Sep; 119():29-37. PubMed ID: 29630973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of a novel venom abstract (ZK002) solution in an alkali-burned corneal wound-healing model.
    Peng WY; Wang F; Yang SJ; Sun QY; Zhou HS; Li X; Jiang ZX; Zhou SY
    Mol Vis; 2023; 29():317-328. PubMed ID: 38264612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Corneal Neovascularization: An Integrated Approach Using Transcriptomics and Proteomics in an Alkali Burn Mouse Model.
    Wang W; Deng M; Li M; Liu L; Zou J; Qian Y
    Invest Ophthalmol Vis Sci; 2024 Jan; 65(1):21. PubMed ID: 38190126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 deletion aggravates corneal neovascularization in a corneal alkali-burn model.
    Li S; Shi S; Xia F; Luo B; Ha Y; Luisi J; Gupta PK; Merkley KH; Motamedi M; Liu H; Zhang W
    Exp Eye Res; 2022 Dec; 225():109265. PubMed ID: 36206861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice.
    Wang Y; Shi S; Zhang L; Wang S; Qin H; Wei Y; Wu X; Zhang M
    Drug Deliv Transl Res; 2024 Mar; ():. PubMed ID: 38494558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Strategies in Treating Corneal Alkali Burns: A Narrative Review.
    Mittal M; Tidake P; Kumar M
    Cureus; 2023 Oct; 15(10):e47662. PubMed ID: 38021904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction: Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1α.
    Biosci Rep; 2024 Jun; 44(6):. PubMed ID: 38818949
    [No Abstract]   [Full Text] [Related]  

  • 12. Alkali Burns of the Skin.
    Milner SM
    Eplasty; 2023; 23():QA12. PubMed ID: 38089840
    [No Abstract]   [Full Text] [Related]  

  • 13. New targets of nascent lymphatic vessels in ocular diseases.
    Wu X; Ma Y; Zhang Z; Hou T; He Y
    Front Physiol; 2024; 15():1374627. PubMed ID: 38529484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages.
    Feng Y; Yang X; Huang J; Shen M; Wang L; Chen X; Yuan Y; Dong C; Ma X; Yuan F
    Oxid Med Cell Longev; 2022; 2022():1106313. PubMed ID: 35345831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7 Inhibits Fibrosis via Wnt/
    Shen M; Feng Y; Wang J; Yuan Y; Yuan F
    Biomed Res Int; 2020; 2020():1216926. PubMed ID: 32566651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging therapies for corneal neovascularization.
    Roshandel D; Eslani M; Baradaran-Rafii A; Cheung AY; Kurji K; Jabbehdari S; Maiz A; Jalali S; Djalilian AR; Holland EJ
    Ocul Surf; 2018 Oct; 16(4):398-414. PubMed ID: 29908870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review).
    Zhou H; Zhang W; Bi M; Wu J
    Int J Mol Med; 2016 Oct; 38(4):1003-11. PubMed ID: 27499172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of TC14012 on alkali burn-induced corneal neovascularization in mice.
    Shen M; Yuan F; Jin J; Yuan Y
    Ophthalmic Res; 2014; 52(1):17-24. PubMed ID: 24853648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
    Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
    Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.